SABRA HEALTH CARE REIT, INC.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $235.9M | $221.8M | $211.9M | $190.0M | $189.2M | $183.5M | $182.3M | $178.0M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $16.8M | $14.9M | $15.9M | $12.6M | $12.5M | $12.7M | $13.0M | $12.4M |
| Operating Income | $3.0M | $67.8M | $54.9M | $50.6M | $92.8M | $67.6M | $75.3M | $58.8M |
| Operating Margin | 1.3% | 30.6% | 25.9% | 26.6% | 49.0% | 36.8% | 41.3% | 33.0% |
| Interest Expense | $29.8M | $28.4M | $28.9M | $28.9M | $27.5M | $27.1M | $28.1M | $29.5M |
| Pretax Income | $-26.8M | $39.4M | $26.0M | $21.7M | $65.2M | $40.5M | $47.2M | $29.3M |
| Income Tax Expense | $678.0K | $526.0K | $491.0K | $436.0K | $497.0K | $413.0K | $380.0K | $-265.0K |
| Net Income | $-25.2M | $40.9M | $27.2M | $22.5M | $65.5M | $40.3M | $46.7M | $29.8M |
| Net Margin | -10.7% | 18.4% | 12.8% | 11.9% | 34.7% | 22.0% | 25.6% | 16.7% |
| EPS (Basic) | $-0.10 | $0.16 | $0.10 | $0.09 | $0.28 | $0.17 | $0.20 | $0.13 |
| EPS (Diluted) | $-0.10 | $0.16 | $0.11 | $0.09 | $0.27 | $0.17 | $0.20 | $0.13 |
| Shares Outstanding (Basic) | 252.3M | 252.1M | 241.3M | 239.9M | 238.0M | 237.9M | 233.5M | 234.3M |
| Shares Outstanding (Diluted) | 252.3M | 256.0M | 244.5M | 243.6M | 240.9M | 240.3M | 236.0M | 237.0M |
| Dividends Per Share | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 |